Renal excretory responses produced by the delta opioid agonist, BW373U86, in conscious rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 238-245

  Sezen, Sena F ^a,b   Kenigs, Velga A ^a   Kapusta, Daniel R ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; NALTRINDOLE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DIURESIS; DOSE RESPONSE; DRUG RECEPTOR BINDING; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NONHUMAN; OSMOLARITY; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; BENZAMIDES; DENERVATION; INFUSIONS, INTRAVENOUS; KIDNEY; MALE; NALTREXONE; OLIGOPEPTIDES; OPIOID PEPTIDES; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA;

EID: 0032454657     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ayres EA, Davis P and Burks TF (1990) In vivo and in vitro investigations of naltrindole, a δ-opioid antagonist. Proc West Pharmacol Soc 33:55-63.
2. Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC and Porreca F (1995) SNC80, A selective, nonpeptidic and systemically active opioid della agonist. J Pharmacol Exp Ther 273:359-366.
3. Bisset GW, Chowdrey HS and Feldberg W (1978) Release of vasopressin by enkephalin. Br J Pharmacol 62:370-371.
4. Brownell J, del Pozo E and Donatsch P (1980) Inhibition of vasopressin secretion by a met-enkephalin (FK 33-824) in humans. Acta Endocrinol 94:304-308.
5. Chang K-J, Rigdon GC, Howard JL and McNutt RW (1993) A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J Pharmacol Exp Ther 267:852-857.
6. Clark MJ, Emmerson PJ, Mansour A, Akil H, Woods JH, Portoghese PS, Remmers AE and Medzihradsky F (1997) Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. 283:501-510.
7. Comer SD, McNutt RW, Chang K-J, De Costa BR, Mosberg HI and Woods JH (1993) Discriminative stimulus effects of BW373U86: A nonpeptide ligand with selectivity for delta opioid receptors. J Pharmacol Exp Ther 267:866-874.
8. DiBona GF and Sawin LL (1983) Renal nerves in renal adaptation to dietary sodium restriction. Am J Physiol 14:F322-F328.
9. DiBona GF and Kopp UC (1997) Neural control of renal function. Physiol Rev 77(1):75-155.
10. Drawer E, Stapelfeld A, Rafferty MF, De Costa BR, Rice KC and Hammond DL (1991) Selective antagonism by naltrindole of the antinociceptive effects of the delta agonist cyclic [D-penicillamine2, D-penicillamine 5]enkephalin in the rat. J Pharmacol Exp Ther 259:725-731.
11. Dykstra LA, Schoenbaum GM, Yarbrough J, McNutt R and Chang K-J (1993) A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration. J Pharmacol Exp Ther 267:875-882.
12. George SR, Zastawny RL, Briones-Urbina R, Cheng R, Nguyen T, Heiber M, Chan AS and O'Dowd BR (1994) Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem Biophys Res Commun 205(2):1438-1444.
13. Grossman A, Besser GM, Milles JJ and Baylis PH (1980) Inhibition of vasopressin release in man by an opiate peptide. Lancet 1108-1110.
14. Gutkowska J and Schiller PW (1996) Renal effects of TAPP, a highly selective μ opioid agonist. Br J Pharmacol 119:239-244.
15. Huidobro F, Diez C, Croxatto R and Huidobro-Toro JP (1981) Morphine antidiuresis in the rat: Biphasic effect of the opiate on the excretion of urine electrolytes. J Pharm Pharmacol 33:815-816.
16. Huidobro F and Huidobro-Toro JP (1979) Antidiuretic effect of morphine and vasopressin in morphine tolerant and nontolerant rats: Differential effects on urine composition. Eur J Pharmacol 59:55-65.
17. Jenab S, Kest B, Franklin SO and Inturrisi CE (1995) Quantitative distribution of the delta opioid receptor mRNA in the mouse and rat CNS. Life Sci 56(26):2343-2355.
18. Kapusta DR (1995) Opioid mechanisms controlling renal function. Clin Exp Pharmacol Physiol 22:891-902.
19. Kapusta DR, Jones SY, Kopp UC and DiBona GF (1989a) Role of renal nerves in excretory responses to exogenous and endogenous opioid peptides. J Pharmacol Exp Ther 248:1039-1047.
20. Kapusta DR, Jones SY and DiBona GF (1989b) Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 251:230-237.
21. Kapusta DR, Jones SY and DiBona GF (1989c) Opioids in the systemic hemodynamic and renal responses to stress in conscious spontaneously hypertensive rats. Hypertension 13:808-816.
22. Kapusta DR, Obih JC and DiBona GF (1993) Central mu opioid receptor mediated changes in renal function in conscious rats. J Pharmacol Exp Ther 265:134-143.
23. Kapusta DR and Obih JC (1993) Central kappa opioid receptor evoked mediated changes in renal function in conscious rats: Participation of renal nerves. J Pharmacol Exp Ther 267:197-203.
24. Kapusta DR and Obih JC (1995) Role of endogenous central opioid mechanisms in maintenance of body sodium balance. Am J Physiol 268(37):R723-R730.
25. Leander JD (1983) A kappa opioid effect: Increased urination in the rat. J Pharmacol Exp Ther 224:89-94.
26. Lee PHK, McNutt RW and Chang K-J (1993) A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat. J Pharmacol Exp Ther 267:883-887.
27. Mansour A, Fox CA, Akil H and Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18(1): 22-29.
28. Marchand C (1970) The diuretic and antidiuretic effect of morphine sulphate in rats. Proc Soc Exp Biol Med 133:1303-1306.
29. Portoghese PS, Sultana M and Takemori AE (1988) Naltrindole, a highly selective and potent nonpeptide δ opioid receptor antagonist. Eur J Pharmacol 146:185-186.
30. Rimoy GH, Bhaskar NK, Wright DM and Rubin PC (1991) Mechanism of diuretic action of spiradoline (U-62066E), a kappa opioid receptor agonist in the human. Br J Pharmacol 32:611-615.
31. Salas SP, Roblero JS, Lopez LF, Tachibana S, Huidobro-Toro JP (1992) [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-Dynorphin-A-(1-8) Ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat. J Pharmacol Exp Ther 262:979-986.
32. Slizgi GR, Taylor CJ and Ludens JH (1984) Effects of the highly selective kappa opioid U50,488 on renal function in the anaesthetized dog. J Pharmacol Exp Ther 230:641-645.
33. Walker LA and Murphy JC (1984) Antinatriuretic effect of acute morphine administration in conscious rats. J Pharmacol Exp Ther 229(2):404-408.
34. Wild KD, McCormick J, Bilsky EJ, Vanderah T, McNutt RW, Chang K-J and Porreca F (1993) Antinociceptive actions of BW373U86 in the mouse. J Pharmacol Exp Ther 267:858-865.
35. Wittert G, Hope P and Pyle D (1996) Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 218:877-881.
36. Yamada K, Imai M and Yoshida S (1989) Mechanism of diuretic action of U-62006E, a kappa opioid receptor agonist. Eur J Pharmacol 160:229-237.
37. Zerbe RL, Henry DP and Robertson GL (1982) A new met-enkephalin analogue suppresses plasma vasopressin in man. Peptides 1:199-201.